• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

National Institutes of Health

Regeneron touts results of NIH-sponsored EYLEA injection study

March 31, 2021 By Sean Whooley

Regeneron - updated

Regeneron Pharmaceuticals (NSDQ:REGN) announced data supporting the use of its EYLEA injection in NPDR patients. Protocol W, a NIH-sponsored trial to evaluate the EYLEA (aflibercept) injection in patients with moderate to severe non-proliferative diabetic retinopathy (NPDR), without center-involved diabetic macular edema (CI-DME), had its initial results published in JAMA Ophthalmology. At two years, the primary […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Optical/Ophthalmic, Pharmaceuticals Tagged With: National Institutes of Health, Regeneron

Fauci: Hundreds of millions of COVID-19 vaccine doses could be ready in January

April 30, 2020 By Nancy Crotti

coronavirus COVID-19

Dr. Anthony Fauci said this morning that hundreds of millions of doses of a vaccine for COVID-19 could be ready by January. In an interview on the Today Show, the director of the National Institute of Allergy and Infectious Diseases said that a vaccine candidate is in the first phase of a clinical trial. If the second […]

Filed Under: Business/Financial News, Clinical Trials, Hospital Care Tagged With: coronavirus, COVID-19, Gilead Sciences, National Institutes of Health

NIH study: Tandem Diabetes artificial pancreas bests other treatments

October 17, 2019 By Sean Whooley

Tandem Diabetes Care - updated logo

A pivotal trial funded by the National Institutes of Health found that an artificial pancreas system from Tandem Diabetes Care (NSDQ:TNDM) was more effective than existing treatments for people with Type 1 diabetes. The Tandem system combines its t:slim X2 insulin pump and Control-IQ advanced hybrid closed-loop technology with a continuous glucose monitor made by DXCM, […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured Tagged With: National Institutes of Health, Tandem Diabetes Care

Louisiana prisoners may get non-FDA-approved naltrexone implant

May 8, 2019 By Nancy Crotti

BioCorRx updated logo

This article has been updated to clarify the BioCorRx’s role in the program. The Louisiana Department of Corrections is working with BioCorRx (OTC:BICX) to offer soon-to-be-released inmates an opioid addiction treatment implant that has not been approved by the FDA. The implant, which contains a compounded form of naltrexone, is one of several medication-assisted options being […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Research & Development, Uncategorized Tagged With: BioCorRx, National Institutes of Health, nationalinstituteondrugabuse

Study: Researchers develop ingestible capsule for insulin delivery

February 11, 2019 By Sarah Faulkner

A team of researchers from MIT developed an ingestible, blueberry-sized capsule that can deliver insulin orally. In animal models, the capsule lowered blood sugar levels and performed comparably with the traditional route of insulin delivery – injections. The capsule features a small needle made of freeze-dried, compressed insulin. The needle is attached to a compressed […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: Brigham & Women's Hospital, Massachusetts Institute of Technology, National Institutes of Health, Novo Nordisk

BioCorRx wins $5.6m grant for sustained release naltrexone implant

January 28, 2019 By Sarah Faulkner

BioCorRx updated logo

BioCorRx (OTC:BICX) announced this month that it won a two-year grant from the NIH’s National Institute on Drug Abuse to support the development of its sustained release naltrexone implant for the treatment of opioid use disorder. The grant includes $2.8 million for Feb. 1, 2019 to Jan. 31, 2020, followed by $2.8 million for the second […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Implants, Pharmaceuticals, Wall Street Beat Tagged With: BioCorRx, National Institutes of Health

NIH kicks off study of combo antibody HIV therapy

September 21, 2018 By Sarah Faulkner

NIH IV bag

The National Institutes of Health reported this week that it launched a clinical trial evaluating a combination of antibodies in people with HIV. The early-stage study is designed to assess whether periodic infusions of two HIV-specific antibodies are safe in people living with HIV. Researchers also plan to gather preliminary data assessing how effectively the […]

Filed Under: Clinical Trials, Featured, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

Researchers launch early-stage trial for nasal flu vaccine

September 18, 2018 By Sarah Faulkner

National Institutes of Health logo

Researchers at St. Louis University reported that an early-stage trial testing an experimental nasal flu vaccine in children and teens began enrolling participants this week. In the 50-person study, half of the participants will receive the investigational nasal vaccine and the other half will receive an inactive saline solution. All of the study’s participants are […]

Filed Under: Clinical Trials, Featured, Pharmaceuticals Tagged With: flugen, National Institutes of Health

NIH study finds daily aspirin does not prolong healthy lifespan

September 17, 2018 By Sarah Faulkner

Pills

In a 19,114-person trial supported by the National Institutes of Health, researchers found that daily low-dose aspirin did not prolong independent living in healthy older adults. Initial findings from the Aspree trial, which began in 2010, were published in The New England Journal of Medicine this week. The study involved participants who did not have […]

Filed Under: Clinical Trials, Featured, Pharmaceuticals Tagged With: National Institutes of Health

NIH launches precision medicine project to collect health data from one million volunteers

May 2, 2018 By Sarah Faulkner

NIH All of Us program

The National Institutes of Health will open national enrollment next week for its All of Us research program, aiming to collect health data from at least one million volunteers across the country. The project, which has been in beta for the last year, will request health and lifestyle data from volunteers using online surveys and […]

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS